More or less. If one term -- mid stage trial -- can encompass both 1) a 10 person unblinded trial with no placebo and 2) a 300 person double blinded, placebo trial that is powered for statistical significance, then the term is meaningless and should be retired.
News 
Market Data 
Discover 
